Laboratory for Structural Neuropathology, RIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan.
J Biol Chem. 2011 May 27;286(21):18664-72. doi: 10.1074/jbc.M111.231209. Epub 2011 Mar 24.
The transactivation response element (TAR) DNA-binding protein-43 (TDP-43) is a nuclear protein that normally regulates transcription and splicing. Abnormal accumulation of insoluble inclusions containing TDP-43 has been recently reported in the affected tissues of amyotrophic lateral sclerosis (ALS) patients. Here, we show that intracellular aggregation of TDP-43 can be triggered by transduction of fibrillar aggregates prepared from in vitro functional TDP-43. Sarkosyl is found to be incapable of solubilizing those intracellularly seeded aggregates of TDP-43, which is consistent with the observation that TDP-43 inclusions in ALS patients are sarkosyl-insoluble. In addition, intracellular seeding in our cell models reproduces ubiquitination of TDP-43 aggregates, which is another prominent feature of TDP-43 inclusions in ALS patients. Although it has been so far difficult to initiate disease-associated changes of TDP-43 using cultured cell models, we propose that a seeding reaction is a key to construct a model to monitor TDP-43 pathologies.
转活化反应元件(TAR)结合蛋白-43(TDP-43)是一种核蛋白,通常可调节转录和剪接。最近有报道称,在肌萎缩侧索硬化症(ALS)患者的病变组织中,存在异常聚集的不溶性包含 TDP-43 的包涵体。在这里,我们表明,通过转导体外功能性 TDP-43 制备的纤维状聚集物,可以触发 TDP-43 的细胞内聚集。发现 Sarkosyl 不能溶解那些细胞内接种的 TDP-43 聚集物,这与 ALS 患者 TDP-43 包涵体不溶于 Sarkosyl 的观察结果一致。此外,我们的细胞模型中的细胞内接种可再现 TDP-43 聚集物的泛素化,这是 ALS 患者 TDP-43 包涵体的另一个突出特征。尽管迄今为止使用培养细胞模型很难引发与疾病相关的 TDP-43 变化,但我们提出,接种反应是构建监测 TDP-43 病理学模型的关键。